Physician

Adam Oppenheim, D.O.

According to 2025 Medicare claims, Adam Oppenheim, D.O. (NPI: 1316386865) practices urology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is FLORIDA UROLOGY PARTNERS, LLP (NPI: 1447401955; TIN: 261300103) and primary practice location at 33701-3622. Oppenheim is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Oppenheim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 386 traditional Medicare patients, billed 2,322 HCPCS/CPT codes, and received $119,327 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,724 prescription claims across 450 beneficiaries totaling $561,741 in drug costs, led by Erleada (Apalutamide). Open Payments data shows 36 records totaling $769. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,236 to $561,741. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	86	248	$23,488
2019	386	1,402	$128,698
2020	382	1,950	$137,316
2021	412	2,005	$157,634
2022	434	1,773	$134,254
2023	392	2,484	$128,286
2024	386	2,322	$119,327

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	83	124	$1,236
2016	38	60	$399
2017	14	20	$255
2018	26	46	$2,827
2019	107	330	$21,393
2020	215	647	$140,821
2021	327	1,029	$243,442
2022	414	1,431	$380,354
2023	459	1,598	$609,401
2024	450	1,724	$561,741

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	103	112	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	114	172	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	111	152	$64
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	161	300	$59
81003	Automated urinalysis test	86	121	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	11	330	$163,614
Myrbetriq	Mirabegron	154	5,569	$83,294
Gemtesa	Vibegron	53	2,250	$35,615
Premarin	Estrogens, Conjugated	45	2,835	$23,301
Testosterone	Testosterone	13	390	$5,401

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$769	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Oppenheim, D.O.?

Tedicare shows public-source Medicare data for Adam Oppenheim, D.O. (NPI 1316386865), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Oppenheim, D.O. have ACO affiliation data?

Adam Oppenheim, D.O. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Adam Oppenheim, D.O.?

Adam Oppenheim, D.O. is linked to FLORIDA UROLOGY PARTNERS, LLP (billing NPI 1447401955) in the available physician profile data.

Does Adam Oppenheim, D.O. have Open Payments data?

Adam Oppenheim, D.O. has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.